Richard Furie
- EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
2023/10/12 by Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen +55 · 42 citations
Medicine · #Systemic Lupus Erythematosus Research #Rheumatoid Arthritis Research and Therapies #Systemic Sclerosis and Related Diseases
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
2011/09/01 by Richard Furie, Michelle Petri, Omid Zamani +18 · 32 citations
Medicine · #Systemic Lupus Erythematosus Research #Multiple Sclerosis Research Studies #Liver Diseases and Immunity
- Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trials
2024/04/03 by Tina Baker, Hoda Sharifian, Paul J Newcombe +23 · 27 citations
Medicine · Immunology and Microbiology · #Systemic Lupus Erythematosus Research #interferon and immune responses #Rheumatoid Arthritis Research and Therapies
- A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosus
2009/08/27 by Daniel J. Wallace, William Stohl, Richard A. Furie +16 · 3 citations
Medicine · #Multiple Sclerosis Research Studies #Rheumatoid Arthritis Research and Therapies #Systemic Lupus Erythematosus Research
- EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update
2025/10/16 by Antonis Fanouriakis, Myrto Kostopoulou, Hans-Joachim Anders +35 · 27 citations
Medicine · #Systemic Lupus Erythematosus Research #Rheumatoid Arthritis Research and Therapies #Renal Transplantation Outcomes and Treatments